FDA Decision Encourages Lamictal Generics
As the FDA cannot approve an abbreviated new drug application (ANDA) for a listed drug that has been withdrawn due to reasons of safety or efficacy// , the agency had to determine the reasons for the withdrawal before approving any generic version.
The investigation found no evidence of safety...
Analysis Shows Lamictal As An Effective Additional Therapy For Treatment of Grand Mal Seizures
Researchers have shown the effectiveness of Lamictal
(lamotrigine) as additional treatment method in children and young people with primary// generalized tonic-clonic (PGTC) seizures.
According to the latest issue of the journal Paediatrics, lamotrigine (LAMICTAL) has been demonstrated to be...
PatientAssistance.com Releases the Top 20 Most Popular Searches for Patient Assistance Programs
7. NEXIUM (390)
8. LIPITOR (389)
9. ABILIFY (361)
10. SINGULAIR (345)
11. TOPAMAX (340)
12. LISINOPRIL (333)
14. Suboxone (319)
15. SYNTHROID (306)
16. AMBIEN (303)
17. OXYCONTIN (302)
18. METFORMIN HCL (297)
19. EFFEXOR XR (291)...
FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
...ears of age or older with partial onset seizures. lamictal
XR reduced seizures in patients who were inadequately controlled on current therapy.
XR reduced the frequency of partial seizures during a 19-week study. More patients who took lamictal
XR had a significant reduction in seizure frequen...
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
...(TM) (lamotrigine) Orally Disintegrating Tablets. lamictal
ODT uses a novel drug-delivery formulation to provide lamictal
in a tablet that has a pleasant taste and disinte...al Sciences. "Orally disintegrating tablets, like lamictal
ODT , offer an option for patients who have diffic...
For Bipolar Depression, Surveyed Experts Indicate That Current and Emerging Therapies Have No Advantage Over Seroquel in Decreasing the Severity of Symptoms
Will Retain Decision Resources' Clinical Gold Standard Status for Bipolar Depression, According to a New Report from Decision Resources
Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily
...gh level of physician comfort in prescribing the drug as an add-on therapy, lamictal
became the epilepsy sales leader in 2007, ahead of the 2007 clinical gold s... now launched in the United States, provides improved convenience over both lamictal
and immediate-release Keppra while retaining a favorable efficacy and safet...
Despite Availability of Generic Equivalents, Two-Thirds of Neurologists Will Continue to Prescribe Branded Anti-Epileptic Drugs to Epilepsy Patients
...cantly by brand.
"Currently, 54 percent of the neurologists we surveyed specify 'no generic substitution' on prescriptions for GlaxoSmithKline's lamictal
and a similar proportion indicate they will specify the same on prescriptions for other AEDs when generic versions of these agents become available," ...
GlaxoSmithKline Presents Innovative Neuroscience Pipeline
-- Four CNS products with potential to be launched or approved in 2008: - Trexima potential "new gold standard" for migraine; - lamictal
XR new once daily treatment for epilepsy; - Lunivia, a successful treatment for insomnia in the US, expected to be launched in Europe; -...
Exposure to Epilepsy Drug During Pregnancy Can Increase Risk of Mental Defects in Newborns
...mpared with an average of 96 for children in the Tegretol group, 94 for the lamictal
group and 95 for the Dilantin group. After adjusting for the mothers' IQ sc...ers took Depakote had IQs below 70, compared with 13% for Tegretol, 11% for lamictal
and 12% for Dilantin. According to researchers, about 2% of all children ha...